These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15217960)

  • 21. Optimizing first-line treatment options for patients with advanced NSCLC.
    Wakelee H; Belani CP
    Oncologist; 2005; 10 Suppl 3():1-10. PubMed ID: 16368866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy for metastatic non-small cell lung cancer].
    Pérol M; Moro-Sibilot D
    Rev Mal Respir; 2005 Dec; 22(6 Pt 2):8S131-6. PubMed ID: 16340849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A meta-analysis of the curative effects of carboplatin-based and cisplatin-based chemotherapeutic regimens on advance non-small cell lung cancer].
    Jiang JW; Liang XH; Zhou XL; Huang RF
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(37):2615-20. PubMed ID: 17198587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
    Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL
    Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer.
    Dooms CA; Pat KE; Vansteenkiste JF
    Expert Rev Anticancer Ther; 2006 Apr; 6(4):531-44. PubMed ID: 16613541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-line treatment for advanced non-small-cell lung cancer.
    Laskin JJ; Sandler AB
    Oncology (Williston Park); 2005 Nov; 19(13):1671-6; discussion 1678-80. PubMed ID: 16425521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy in the treatment of non-small cell lung cancer.
    Hainsworth JD
    Am Fam Physician; 1997 May; 55(6):2265-72. PubMed ID: 9149654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party].
    Sculier JP; Paesmans M; Libert P; Bureau G; Dabouis G; Thiriaux J; Michel J; Van Cutsem O; Schmerber J; Giner V; Berchier MC; Mommen P; Sergysels R; Klastersky J
    Rev Mal Respir; 1997 Dec; 14(6):445-9. PubMed ID: 9496602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New agents in advanced non-small-cell lung cancer treatment.
    Ricciardi S; de Marinis F
    Oncology; 2009; 77 Suppl 1():103-12. PubMed ID: 20130438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What does chemotherapy have to offer patients with advanced-stage non-small cell lung cancer?
    Kris MG
    Semin Oncol; 1998 Jun; 25(3 Suppl 8):1-4. PubMed ID: 9704668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future directions in the treatment of non-small cell lung cancer.
    Comis RL; Finley RS
    Semin Oncol; 1999 Dec; 26(6 Suppl 18):14-8. PubMed ID: 10892574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medical treatment of pulmonary neoplasms].
    Crinò L; Calandri C
    Recenti Prog Med; 2001 Feb; 92(2):133-6. PubMed ID: 11294106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recent development in the treatment of lung cancer: from the point of view of the medical oncologist].
    Joss R
    Schweiz Med Wochenschr; 2000 May; 130(19):684-90. PubMed ID: 10846762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy in non-small cell lung cancer: results of recent trials.
    Gralla RJ; Kris MG
    Semin Oncol; 1988 Jun; 15(3 Suppl 4):2-5. PubMed ID: 2839904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adjuvant chemotherapy in non-small cell lung cancer].
    Taillade L; Soria JC; André F; Grunenwald D; Dunant A; Pignon JP; Le Chevalier T
    Bull Cancer; 2004 Jan; 91(1):63-7. PubMed ID: 14975806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic overview of chemotherapy effects in non-small cell lung cancer.
    Sörenson S; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):327-39. PubMed ID: 11441939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of targeted therapy in non-small cell lung cancer: hype or hope?
    Langer CJ
    Expert Rev Anticancer Ther; 2003 Aug; 3(4):443-55. PubMed ID: 12934657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in chemotherapy for small cell lung cancer: single-agent activity of newer agents.
    Argiris A; Murren JR
    Cancer J; 2001; 7(3):228-35. PubMed ID: 11419031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introduction to the treatment of lung cancer.
    Splinter TA
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-1-S12-5. PubMed ID: 9331110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a standard regimen for first-line treatment of advanced/metastatic Non-Small-Cell Lung Cancer? What has meta-analyses contributed to today's standard of care.
    Pallis AG; Georgoulias V
    Lung Cancer; 2012 Mar; 75(3):269-74. PubMed ID: 21996086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.